Form 8-K - Current report:
SEC Accession No. 0001601830-25-000174
Filing Date
2025-12-08
Accepted
2025-12-08 07:31:44
Documents
59
Period of Report
2025-12-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20251208.htm   iXBRL 8-K 22183
2 EX-99.1 exhibit991-fappr.htm EX-99.1 37963
3 EX-99.2 fapdecember2025webinarde.htm EX-99.2 61436
7 fapdecember2025webinarde001.jpg GRAPHIC 116370
8 fapdecember2025webinarde002.jpg GRAPHIC 237152
9 fapdecember2025webinarde003.jpg GRAPHIC 149490
10 fapdecember2025webinarde004.jpg GRAPHIC 82643
11 fapdecember2025webinarde005.jpg GRAPHIC 110827
12 fapdecember2025webinarde006.jpg GRAPHIC 95372
13 fapdecember2025webinarde007.jpg GRAPHIC 101731
14 fapdecember2025webinarde008.jpg GRAPHIC 143865
15 fapdecember2025webinarde009.jpg GRAPHIC 141824
16 fapdecember2025webinarde010.jpg GRAPHIC 151277
17 fapdecember2025webinarde011.jpg GRAPHIC 44760
18 fapdecember2025webinarde012.jpg GRAPHIC 155760
19 fapdecember2025webinarde013.jpg GRAPHIC 122129
20 fapdecember2025webinarde014.jpg GRAPHIC 168148
21 fapdecember2025webinarde015.jpg GRAPHIC 160736
22 fapdecember2025webinarde016.jpg GRAPHIC 143363
23 fapdecember2025webinarde017.jpg GRAPHIC 109344
24 fapdecember2025webinarde018.jpg GRAPHIC 60848
25 fapdecember2025webinarde019.jpg GRAPHIC 125403
26 fapdecember2025webinarde020.jpg GRAPHIC 99444
27 fapdecember2025webinarde021.jpg GRAPHIC 136247
28 fapdecember2025webinarde022.jpg GRAPHIC 143415
29 fapdecember2025webinarde023.jpg GRAPHIC 117174
30 fapdecember2025webinarde024.jpg GRAPHIC 114156
31 fapdecember2025webinarde025.jpg GRAPHIC 156542
32 fapdecember2025webinarde026.jpg GRAPHIC 150780
33 fapdecember2025webinarde027.jpg GRAPHIC 40225
34 fapdecember2025webinarde028.jpg GRAPHIC 102290
35 fapdecember2025webinarde029.jpg GRAPHIC 135945
36 fapdecember2025webinarde030.jpg GRAPHIC 109053
37 fapdecember2025webinarde031.jpg GRAPHIC 55851
38 fapdecember2025webinarde032.jpg GRAPHIC 69968
39 fapdecember2025webinarde033.jpg GRAPHIC 152481
40 fapdecember2025webinarde034.jpg GRAPHIC 23175
41 fapdecember2025webinarde035.jpg GRAPHIC 127074
42 fapdecember2025webinarde036.jpg GRAPHIC 71260
43 fapdecember2025webinarde037.jpg GRAPHIC 61446
44 fapdecember2025webinarde038.jpg GRAPHIC 171561
45 fapdecember2025webinarde039.jpg GRAPHIC 115901
46 fapdecember2025webinarde040.jpg GRAPHIC 122098
47 fapdecember2025webinarde041.jpg GRAPHIC 120929
48 fapdecember2025webinarde042.jpg GRAPHIC 120826
49 image_0.jpg GRAPHIC 385133
50 image_1.jpg GRAPHIC 322824
51 image_2.jpg GRAPHIC 487365
  Complete submission text file 0001601830-25-000174.txt   8722502

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20251208.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20251208_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20251208_pre.xml EX-101.PRE 12512
61 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20251208_htm.xml XML 2746
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 251554637
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)